PubMed · 56596
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
1976-04-10. Editorial: After dopa.. https://pubmed.ncbi.nlm.nih.gov/56596/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
Apomorphine in combination with a peripheral dopamine receptor blocker (domeperidone) was administered to four parkinsonian patients in a double-blind placebo-controlled study. The therapeutic efficacy of apomorphine was not reduced by domperidone, while nausea, drowsiness, sedation, and arterial hypotension were prevented. Combination of domperidone with dopamine agonists may result in more effective treatment of Parkinson's disease.
Explore the source record for details and available documents.